Doctors to study anti-inflammatory drug as potential COVID-19 treatment
Friday, May 8, 2020 - 15:30
in Health & Medicine
Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory drug approved by the Food and Drug Administration to treat rheumatoid arthritis, as a possible treatment for patients with moderate to severe COVID-19. “We are learning that in some COVID-19 cases, inflammation might be driving the […]